The MarketReader Minute
π Amgen Reached a 22-week High, Biogen Rises on Approval, Despite Legal Challenges | Biotech Sector Insights
Macro events such as lower-than-expected US core inflation rates may have impacted market dynamics and potentially affected biotech stock movements due to historical patterns related to this indicator.